What does the evidence say about Protein Supplementation Satiety Meta-Analysis?

The current Migaku evidence database contains 2 reusable source documents for Protein Supplementation Satiety Meta-Analysis. This answer focuses on benefits, uncertainty, and practical interpretation. - Randomized clinical trials consistently report mean weight loss ranging from approximately 15% to more than 20% of total body weight, accompanied by improvements in glycemic control, cardiometabolic risk factors, and obesity-related comorbidities [,,]. [Zambrano-Villacres Raynier (2026); evidence level 3] - As a result, pharmacotherapy is increasingly positioned as an important component of contemporary obesity treatment algorithms rather than a secondary or last-line option []. [Zambrano-Villacres Raynier (2026); evidence level 3] - 20 20 20 21 22 23 24 25 26 Emerging real-world evidence indicates that a substantial proportion of individuals initiating GLP-1 receptor agonist therapy discontinue treatment within the first year []. [Zambrano-Villacres Raynier (2026); evidence level 3] - 1 2 3 4 5 6 7 8 9 The therapeutic landscape of obesity management has changed profoundly with the clinical introduction and rapid uptake of glucagon-like peptide-1 (GLP-1) receptor agonists and dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonists (GLP-1RAs) [,]. [Zambrano-Villacres Raynier (2026); evidence level 3] - And for the last several decades, researchers have continued to provide evidence for the benefits of higher fiber intake, especially for cereal fibers, on an array of health outcomes, with the greatest effects reported among low-fiber consumers and consumers of Western-style diets (–). [Comerford Kevin B. (2026); evidence level 3] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.